MOVA Life brings its smart health home vision to Silicon Valley
SAN JOSE, Calif., Jan. 16, 2026 /PRNewswire/ -- Global smart technology brand MOVA hosted its 2026 global strategy and product launch event at AGI House in Silicon Valley, unveiling a new brand positioning and showcasing its expanding smart health...
Tuwaiq Sculpture 2026 Returns to Riyadh for Its Seventh Edition Under the Theme "Traces of What Will Be"
RIYADH, Saudi Arabia, Jan. 14, 2026 /PRNewswire/ -- The Royal Commission for Riyadh City, through Riyadh Art, announces the return of Tuwaiq Sculpture 2026, marking the seventh edition of the annual international sculpture symposium. The program...
FMF's 5th Ministerial Roundtable Concludes with 100 Governments and 59 Multilaterals, Laying Framework for a New Age of Minerals Development
RIYADH, Saudi Arabia, Jan. 14, 2026 /PRNewswire/ -- The 5th Ministerial Roundtable, which forms part of the Future Minerals Forum (FMF), concluded in Riyadh, marking a significant milestone in global cooperation on minerals and reinforcing the shift...
Head-to-Head Real-World dаta: Cadonilimab Outperforms PD-1 Inhibitors in First-Line PD-L1-Low Gastric Cancer
HONG KONG, Jan. 14, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) announced the presentation of a real-world study at the 2026 American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI), comparing cadonilimab plus chemotherapy...
TCL Note A1 NXTPAPER Achieves Multiple Awards at CES and Launches Pre-sale, Redefining the E-Note Experience
IRVINE, Calif., Jan. 14, 2026 /PRNewswire/ -- At the recently concluded Consumer Electronics Show (CES 2026), the TCL Note A1 NXTPAPER, an e-note device featuring TCL's revolutionary NXTPAPER display technology, became a major highlight with its...
Immunofoco Presents Phase I/IIa Data of IMC002 at ASCO GI 2026, Highlighting a Durable Complete Response Beyond One Year and a 66.7% ORR in Advanced GC/GEJ
SHANGHAI, Jan. 13, 2026 /PRNewswire/ -- Immunofoco, a clinical-stage biotechnology company advancing innovative CAR-T cell therapies for solid tumors, recently announced clinical data from its Phase I/IIa study of IMC002, a VHH-based anti-CLDN18.2...
AISpeech's Smart Mobility Solutions Debut at CES 2026
LAS VEGAS, Jan. 13, 2026 /PRNewswire/ -- At CES 2026 in Las Vegas, The article is from Shuzhi Society: AISpeech, a leading conversational AI platform provider, presented its latest breakthroughs in the intelligent mobility sector. With a focus on...
Novo Nordisk's GLP‑1 RA--A Modern Treatment for Obesity Management--is Linked to Lower Household Spending on Alcohol and Tobacco
Real-world data analysis suggests that families with at least one member using Novo Nordisk's GLP‑1 RA for weight management tend to reduce spending on alcohol and cigarettes. JAKARTA, Indonesia, Jan. 12, 2026 /PRNewswire/ -- At the international...
Lynk Pharmaceuticals Announces Positive Phase III Topline Data of Zemprocitinib (LNK01001) in Rheumatoid Arthritis
HANGZHOU, China, SHANGHAI and BOSTON, Jan. 12, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals"), a clinical stage innovative drug development company focused on developing innovative therapies...
NAVEE Expands into Outdoor and Lifestyle Mobility at CES 2026
LAS VEGAS, Jan. 8, 2026 /PRNewswire/ -- NAVEE, a global smart mobility brand, unveiled its latest outdoor-focused innovations at CES® 2026, highlighting its continued expansion from urban mobility into broader lifestyle, recreation, and outdoor...